Skip to search formSkip to main contentSkip to account menu

perfluoropentane

Known as: Dodecafluoropentane 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Fluorocarbons

Narrower (1)

NVX-108
perflenapent

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Targeted and ultrasound-triggered cancer cell injury using perfluorocarbon emulsion-loaded liposomes endowed with cancer cell-targeting and fusogenic capabilities.
2014
2014
Hollow iron-silica nanoshells for enhanced high intensity focused ultrasound.
2010
2010
Fluid adsorption in ordered mesoporous solids determined by in situ small-angle X-ray scattering.
The adsorption of two organic fluids (n-pentane and perfluoropentane) in a periodic mesoporous silica material (SBA-15) is… 
1999
1999
Flow dynamics of QW7437, a new dodecafluoropentane ultrasound contrast agent, in the microcirculation: microvascular mechanisms for persistent tissue echo enhancement.
Review
1999
Review
1999
Doppler sonographic enhancement of hepatic hemangiomas and hepatocellular carcinomas after perflenapent emulsion: preliminary study.
Ultrasonographic microbubble contrast agents improve Doppler signals by increasing blood backscatter. We retrospectively reviewed… 
1999
1999
Persistent opacification of the left ventricle and myocardium with a new echo contrast agent.
Highly Cited
1998
Highly Cited
1998
Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal…
1997
1997
Safety and efficacy of QW7437, a new fluorocarbon-based echocardiographic contrast agent.
1996
1996
Reduction in left ventricular cavitary attenuation and improvement in posterior myocardial contrast with higher molecular weight intravenous perfluorocarbon-exposed sonicated dextrose albumin…
Highly Cited
1995
Highly Cited
1995
Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)